SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc., a privately held dermatology company commercializing non-invasive gene expression tests for skin cancer, announces the presentation of a poster at the 2015 American Academy of Dermatology’s Annual Meeting. The presentation entitled, “Melanoma gene expression in adhesive-tape sampled lesions is similar in primary tumors and patient derived xenografts.” further validates the ability of DermTech’s propriety Pigmented Lesion Assay to differentiate melanoma tissue from non-melanoma tissue.
Help employers find you! Check out all the jobs and post your resume.
